White-Faced Hornet VIT: When the Nest Is the Diagnosis
White-faced hornet (Dolichovespula maculata, also called bald-faced hornet) is a Dolichovespula — not a true Vespa hornet — recognizable by its distinctive black-and-white aerial paper nests. Disturbing the nest can trigger multiple simultaneous stings, raising total venom load and anaphylaxis risk substantially above a single yellow-jacket sting. FDA-standardized VIT is available as single-venom (100 μg) or as the mixed-vespid extract covering all three vespids.
White-Faced Hornet Allergy Immunotherapy: How It Works
Allergy immunotherapy is the only long-term treatment that re-trains the immune system to stop overreacting to white-faced hornet — rather than just masking symptoms with antihistamines or steroids. By gradually exposing the body to controlled doses of white-faced hornet allergen, immunotherapy shifts the underlying allergic response and produces relief that often outlasts treatment by 7–10 years.
There are two evidence-based forms of white-faced hornet immunotherapy used today, both built on the same desensitization principle but delivered very differently.
of sustained relief after a complete immunotherapy course — the only allergy treatment with proven long-term effect after stopping.
Allergy Shots (SCIT)
Weekly injections of white-faced hornet extract in a clinic, escalating over 3–6 months until a maintenance dose is reached. Continued monthly for 3–5 years. Longest clinical track record for white-faced hornet allergy.
- Strongest evidence base for severe and polysensitized patients
- Covered by most insurance plans
- Requires 50–100+ in-person clinic visits across the full course
Allergy Drops / Tablets (SLIT)
Daily drops or dissolvable tablets containing white-faced hornet extract, held under the tongue at home. Same desensitization principle, delivered without injections. WHO-recognized as an effective form of allergy immunotherapy since 2001.
- Taken at home — no weekly clinic trips, no needles
- Lower systemic reaction rate than allergy shots
- Curex offers prescription white-faced hornet immunotherapy drops with allergist oversight
The rest of this page goes deep on allergen-specific immunotherapy with shots — protocol, efficacy data, side effects, and cost. If you’d rather skip the clinic and treat white-faced hornet allergy with at-home drops, see how Curex sublingual immunotherapy compares below.
What is White-Faced Hornet?
The biology, taxonomy, and clinical fingerprint of White-Faced Hornet — the foundation of how SCIT targets it.
Dolichovespula maculata — the white-faced (bald-faced) hornet; its black-and-white aerial paper nest, up to 14 inches in diameter, is the most distinctive species-identification cue in US stinging-insect allergy.
- Scientific name
- Dolichovespula maculata
- Family
- VespidaeWasp and hornet family
- Type
- Hymenoptera venom (aerial-nesting Dolichovespula; smooth retractable stinger; multiple stings per encounter)
- Native to
- Continental US and Canada; most abundant in the East and Pacific Northwest
- Allergen proteins
- Dol m 1 — Phospholipase A1 (34 kDa; major allergen)Dol m 2 — Hyaluronidase (38 kDa; major allergen)Dol m 5 — Antigen 5 (23 kDa; dominant major allergen; 204 residues, α-β-α sandwich; recognized by all hornet-venom–sensitive patients tested per Lu 1993 J Immunol 150:2823)
- Particle size
- N/A (venom protein, not pollen)
- Avoidance difficulty
- Moderate
How White-Faced Hornet Allergy Presents
Symptoms by body system — useful for distinguishing White-Faced Hornet sensitivity from overlapping allergies and infections.
Systemic (Anaphylaxis)
- Generalized urticaria and flushing within minutes of sting
- Throat tightness, stridor, and difficulty breathing
- Hypotension and cardiovascular collapse in severe reactions
- Loss of consciousness in the most severe cases
- Nausea, vomiting, and abdominal cramping
Local / Dermal
- Immediate pain and erythema at each sting site
- Multiple simultaneous sting sites from nest disturbance
- Large local reactions >10 cm at individual sites
- Pruritis and induration
Respiratory (in systemic reaction)
- Bronchospasm and wheezing
- Laryngeal edema producing stridor
- Upper airway obstruction requiring urgent epinephrine
Ocular
- Periorbital angioedema
- Conjunctival injection and tearing
- Eyelid swelling
White-faced hornet patients almost always describe the nest — that black-and-white basketball hanging in the tree. The clinical detail that actually changes management is multiple stings: one yellow jacket gives about 2 to 10 micrograms of venom, but a disturbed bald-faced hornet nest can deliver 10 or 20 stings in seconds, which raises both the toxic and the allergic risk dramatically.
When & Where White-Faced Hornet Peaks
Allergen intensity by month and by state. Useful for timing SCIT start dates and travel planning.
12-Month Intensity
Peak: July through October; colonies are largest and most aggressive in late summer and early autumn· ~5 months of active colonies; nests are abandoned by first hard frost
US Exposure Map
15 high-intensity statesWhat White-Faced Hornet Cross-Reacts With
Patients sensitized to one allergen often react to others sharing similar proteins. This map shows the documented molecular overlaps.
White-faced hornet's Dol m 5 Antigen 5 is the most-studied member of the vespid Antigen 5 family, sharing near-complete cross-reactivity with yellow hornet and 60–95% cross-reactivity with yellow jacket, making it the structural anchor of the mixed-vespid product.
Dol m 5 ↔ Dol a 5 Antigen 5, ~95% cross-reactivity — the closest Dolichovespula relative (Lu 1993 J Immunol 150:2823)
Dol m 5 ↔ Ves v 5 Antigen 5, 60–95% cross-reactivity; primary basis for the mixed-vespid product
Is SCIT Right for Your White-Faced Hornet Allergy?
Answer 5 questions to assess your VIT candidacy for white-faced hornet sting allergy and whether the single-venom or mixed-vespid approach is most appropriate for your situation.
How severe was your reaction to the white-faced hornet sting (or nest encounter)?
The White-Faced Hornet SCIT Protocol
White-faced hornet VIT is FDA-standardized and administered in an allergist's office with a mandatory 30-minute post-injection observation period; the multiple-sting risk from nest disturbance makes VIT especially important for patients who work or live in environments where nest encounters are likely.
Dose escalation proceeds from the most dilute vial to the 100 μg (single venom) or 300 μg (mixed vespid) maintenance target, with a mandatory 30-minute observation period after every injection. Vespid VIT has approximately 2% systemic-reaction rate during build-up (Sturm 2002 JACI 110:928) — substantially lower than honey bee VIT. Rush build-up (3–7 days) is an option at experienced centers.
Standard maintenance is 100 μg per single white-faced hornet venom injection or 300 μg total for mixed vespid. Given the high Antigen 5 cross-reactivity across vespids, the mixed-vespid product provides equivalent or superior vespid coverage. Dose increased to 200 μg for breakthrough reactions or mast cell disorder. Mast cell disorder workup (baseline tryptase) is recommended for all severe vespid reactors.
After completing a full VIT course, most patients achieve lasting re-sting tolerance. Lifelong continuation is indicated for mast cell disorder (baseline tryptase >11.4 ng/mL), prior near-fatal anaphylaxis (loss of consciousness, cardiovascular collapse), or systemic reaction during VIT (Golden 2017; Sturm 2018 Allergy 73:744).
Extract Concentration Ladder
You progress through each vial during build-up. Concentration increases ~10x per step.
What the Research Shows for White-Faced Hornet SCIT
White-faced hornet VIT shares the efficacy framework of the broader Hymenoptera VIT evidence base, anchored by Hunt 1978 NEJM and confirmed by Boyle 2012 Cochrane — a 90% reduction in re-sting systemic-reaction risk compared to untreated patients.
- Re-sting systemic reaction risk reduction (VIT vs untreated across Hymenoptera)90%Boyle 2012, Cochrane CD008838 — RR 0.10 (2.7% VIT vs 39.8% untreated)
- Vespid VIT efficacy (yellow jacket as the vespid benchmark)97%Müller 1992, JACI 89:529 — vespid VIT 95–98% re-sting protection
- Long-term field re-sting systemic reaction rate after ≥5 yr VIT97%Golden 1996, JACI 97:579 — 3% of field re-stings produced systemic reaction after ≥5 yr
White-faced hornet VIT's efficacy derives from the same Antigen 5 cross-protection backbone as yellow jacket VIT — no separate white-faced hornet–specific RCT exists, but the high Dol m 5 / Ves v 5 cross-reactivity means patients treated with mixed-vespid extract achieve coverage levels consistent with the vespid VIT literature (Müller 1992; Boyle 2012 Cochrane).
Ready to skip the surprise bills?
See if at-home allergy shots fit your allergies — a 2-minute quiz, designed by board-certified allergists, with flat monthly pricing and no clinic visits.
- 4.8/5Patient rating
- $129/moFlat pricing
- 50K+Patients treated
- HSA/FSAEligible
White-Faced Hornet SCIT Side Effects
White-faced hornet VIT carries the same safety profile as other vespid immunotherapies — systemic reactions during build-up occur in approximately 2% of patients, with large local reactions more common at 30–50%.
Local reactions
3 documentedSystemic reactions
3 documentedAll VIT injections must be administered in an allergist's office with on-site epinephrine and a mandatory 30-minute observation period. Multiple-sting encounters from a white-faced hornet nest disturbance should be reported to your allergist immediately as a change in exposure risk.
SCIT vs Alternatives for White-Faced Hornet
For white-faced hornet sting allergy, VIT via the mixed-vespid extract is the definitive treatment; avoidance of aerial nests and epinephrine rescue are the mainstays for patients who cannot commit to VIT.
| Criterion | VIT (Mixed Vespid)Best | Avoidance Only | Epinephrine Rescue | Antihistamines |
|---|---|---|---|---|
| Effectiveness | 95–98% re-sting protection via Ag5 cross-reactivity (Müller 1992) | Reduces exposure; counseled on nest identification and professional removal | Rescue treatment; does not prevent anaphylaxis from nest encounter | Do not prevent white-faced hornet anaphylaxis |
| 5-yr cost | $2,000–$8,000 over 3–5 yr | Cost of auto-injectors only | $300–$600/yr auto-injector refills | Low cost |
| Duration | 3–5 yrs (lifelong if mast cell dx) | Ongoing indefinitely | Ongoing; not curative | Daily ongoing |
| Convenience | Weekly clinic visits build-up; monthly maintenance | No clinic visits; requires active nest monitoring | Must carry at all times | Oral, convenient |
| Safety profile | ~2% systemic reactions during build-up | Safe if not stung; ~60% systemic-reaction risk on re-sting | Bridge to emergency care; risk of delay | Safe; ineffective for venom anaphylaxis |
| Lasting effect | Durable; skin-test negativity in majority post-VIT | No immunologic change | No desensitization | No lasting effect |
VIT (Mixed Vespid)Best
Avoidance Only
Epinephrine Rescue
Antihistamines
The mixed-vespid extract is the most practical VIT approach for white-faced hornet allergy, covering this species alongside yellow jacket and yellow hornet under the same maintenance injection given in your allergist's office. For patients who also experience inhalant allergies from cat, dog, dust mite, or seasonal pollens, Curex addresses those comorbid sensitivities with a different product entirely: a personalized, allergist-overseen immunotherapy serum taken as one weekly at-home shot at $129/month — separate from the in-clinic VIT for vespid venom.
What White-Faced Hornet SCIT Actually Costs
White-faced hornet VIT is covered by most US health insurers as part of standard allergy benefits for documented Hymenoptera sting anaphylaxis. Prior authorization is required for the venom extract preparation (CPT 95165). Whether single white-faced hornet venom or the mixed-vespid product is prescribed affects the total cost. Curex at-home IgE testing identifies specific white-faced hornet sensitization before allergist consultations, eliminating the need for an initial skin-test visit.
Cost range varies by deductible, co-insurance, and clinic.
Verify these codes with your insurer to confirm coverage.
Flat monthly subscription — includes consult, prescription, and at-home dosing for sublingual immunotherapy.
See if you qualifyStop guessing about your white-faced hornet allergy. Get a plan.
Take Curex’s 3-minute allergy quiz. A board-certified allergist will review your symptoms and recommend the right immunotherapy path for you — shots or drops.
Free quiz · Board-certified allergists · 50,000+ patients treated · HSA/FSA eligible
White-Faced Hornet SCIT — Frequently Asked
Quick answers to the questions patients ask most before starting treatment.
White-faced hornet (Dolichovespula maculata) is distinctive primarily because nest disturbance reliably triggers multiple stings rather than a single sting event. A single yellow jacket delivers approximately 2–10 μg of venom per sting; a disturbed white-faced hornet nest can deliver 10 or 20 stings within seconds, raising total venom load substantially. This multiple-sting pattern is why VIT candidacy assessment for white-faced hornet patients should account for cumulative venom exposure, not just single-sting reaction severity. The species is also identifiable by its iconic black-and-white aerial paper nest — the most reliable visual species-identification cue in US stinging-insect allergy.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.